Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma
10.3347/kjp.2021.59.4.363
- Author:
Isabelle JALA
1
;
Muhammad Luthfi ALMANFALUTHI
;
Thewarach LAHA
;
Sakawrat KANTHAWONG
;
Sirikachorn TANGKAWATTANA
;
Prasert SAICHUA
;
Sutas SUTTIPRAPA
;
Banchob SRIPA
Author Information
1. Tropical Medicine Graduate Program (International Program), Academic Affairs, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
- Publication Type:Original Article
- From:The Korean Journal of Parasitology
2021;59(4):363-368
- CountryRepublic of Korea
- Language:English
-
Abstract:
Despite the synergistic effect of Opisthorchis viverrini and Helicobacter pylori co-infection on pathogenesis of severe hepatobiliary abnormalities (HBA) including advanced periductal fibrosis and replace with cholangiocarcinoma (CCA) have been established, the immune response to H. pylori in O. viverrini infected population has never been explored. Hence, this study aimed to investigate the antibody responses to 2 immunogenic H. pylori proteins in O. viverrini-infected patients with HBA and CCA. The risk analysis by multinomial logistic regression revealed that GroEL seropositivity was associated with higher risks of hepatobiliary abnormalities and CCA with adjusted odds ratios (95% confidence intervals) of 2.11 (95% CI=1.20-3.71, P=0.008) and 2.13 (95% CI=1.21-3.75, P=0.009), respectively. These findings indicate that GroEL seropositivity might be a biomarker for early detection of O. viverrini associated HBA and CCA.
